Notify me when Benjamin Hohl files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Chief Financial Officer | $1,548,180 | -$629,583 | -29% | 12 Feb 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|